Price T Rowe Associates Inc Evolent Health, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Evolent Health, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 715,905 shares of EVH stock, worth $8.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

715,905

Previous 722,959 0.98%

Holding current value

$8.07 Million

Previous $13.8 Million 46.46%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$18.41 - $32.97 $129,864 - $232,570	-7,054 Reduced 0.98%	715,905 $20.2 Million
Q2 2024 Aug 14, 2024	BUY	$19.12 - $31.93 $107,550 - $179,606	5,625 Added 0.78%	722,959 $13.8 Million
Q1 2024 May 15, 2024	BUY	$29.41 - $34.72 $2.22 Million - $2.62 Million	75,376 Added 11.74%	717,334 $23.5 Million
Q4 2023 Feb 14, 2024	BUY	$23.63 - $33.52 $96,410 - $136,761	4,080 Added 0.64%	641,958 $21.2 Million
Q3 2023 Nov 14, 2023	SELL	$25.0 - $31.4 $5.31 Million - $6.67 Million	-212,383 Reduced 24.98%	637,878 $17.4 Million
Q2 2023 Aug 14, 2023	BUY	$28.05 - $36.44 $177,191 - $230,191	6,317 Added 0.75%	850,261 $25.8 Million
Q1 2023 May 15, 2023	SELL	$26.35 - $35.8 $83,924 - $114,022	-3,185 Reduced 0.38%	843,944 $27.4 Million
Q4 2022 Feb 14, 2023	BUY	$22.21 - $37.41 $2.09 Million - $3.52 Million	94,043 Added 12.49%	847,129 $23.8 Million
Q3 2022 Nov 14, 2022	BUY	$29.37 - $39.74 $21 Million - $28.4 Million	715,327 Added 1894.45%	753,086 $27.1 Million
Q2 2022 Aug 15, 2022	BUY	$25.9 - $32.26 $87,593 - $109,103	3,382 Added 9.84%	37,759 $1.16 Million
Q1 2022 May 16, 2022	BUY	$22.14 - $32.3 $96,087 - $140,182	4,340 Added 14.45%	34,377 $1.11 Million
Q4 2021 Feb 14, 2022	SELL	$25.36 - $34.11 $127,687 - $171,743	-5,035 Reduced 14.36%	30,037 $831,000
Q3 2021 Nov 15, 2021	SELL	$20.93 - $31.0 $31,395 - $46,500	-1,500 Reduced 4.1%	35,072 $1.09 Million
Q2 2021 Aug 16, 2021	SELL	$18.43 - $21.78 $12,182 - $14,396	-661 Reduced 1.78%	36,572 $772,000
Q1 2021 May 17, 2021	SELL	$16.19 - $21.22 $64,290 - $84,264	-3,971 Reduced 9.64%	37,233 $752,000
Q4 2020 Feb 16, 2021	BUY	$9.92 - $16.43 $408,743 - $676,981	41,204 New	41,204 $661,000

Others Institutions Holding EVH

# of Institutions

306

Shares Held

124M

Call Options Held

2.13M

Put Options Held

2.64M

View Full List

About Evolent Health, Inc.

Ticker EVH
Exchange NYSE
Sector Healthcare
Industry Health Information Services
Shares Outstandng 97,063,696
Market Cap $1.09B
Description
Evolent Health, Inc., a healthcare company, through its subsidiary, Evolent Health LLC, provides clinical and administrative solutions to payers and providers in the United States. It operates in two segments, Evolent Health Services and Clinical Solutions. The Evolent Health Services segment provides an integrated administrative and clinical pl...

More about EVH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Evolent Health, Inc. Transaction History